Home / Companies / INmune Bio Inc. / 18 Nov 2025
INmune Bio Inc.: meeting of 18 Nov 2025
Votes reported on Form N-PX, item by item
40 Form N-PX filers reported votes at the INmune Bio Inc. meeting of 18 Nov 2025. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
1 vote records from 1 filers. No filer marked a management recommendation, so no against-management figure is reported. 1 filer reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
66 vote records from 37 filers. 36 of the 36 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
69 vote records from 39 filers. 38 of the 38 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
None of the families tracked on this site reported a position on these items.
Questions
How did large funds vote at the INmune Bio Inc. meeting?
40 Form N-PX filers reported votes at the meeting of 18 Nov 2025. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by INmune Bio Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for INmune Bio Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing INmune Bio Inc. with a meeting date within three days of 18 Nov 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.